News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
FLESHER GREGORY J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/13/2022 |
4
| FLESHER GREGORY J. (President and CEO) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 300,000 options to buy
@ $1.8, valued at
$540k
|
|
| 12/14/2021 |
4
| FLESHER GREGORY J. (President and CEO) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 shares
@ $0
Granted 200,000 options to buy
@ $6.69, valued at
$1.3M
|
|
| 08/26/2021 |
4
| FLESHER GREGORY J. (President and CEO) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Bought 8,000 shares
@ $8, valued at
$64k
|
|
| 04/08/2021 |
3
| FLESHER GREGORY J. (President and CEO) has filed a Form 3 on Reneo Pharmaceuticals, Inc. |
| 03/20/2020 |
4
| FLESHER GREGORY J. (CEO) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.26, valued at
$52k
|
|
| 09/30/2019 |
4
| FLESHER GREGORY J. (CEO) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.67, valued at
$67k
|
|
| 07/29/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/22/2019 |
4
| FLESHER GREGORY J. (CEO) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Sold 11,701 shares
@ $1.9616, valued at
$23k
Sold 2,937 shares
@ $1.9114, valued at
$5.6k
|
|
| 03/18/2019 |
4
| FLESHER GREGORY J. (CEO) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 25,000 shares
@ $0
Granted 90,000 options to buy
@ $3.72, valued at
$334.8k
|
|
| 03/15/2018 |
4
| FLESHER GREGORY J. (CEO) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 30,700 shares
@ $0
Granted 56,500 options to buy
@ $4.83, valued at
$272.9k
|
|
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/11/2017 |
4
| FLESHER GREGORY J. (CEO) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Bought 58,959 shares
@ $9.99, valued at
$589k
|
|
| 05/11/2017 |
3
| FLESHER GREGORY J. (CEO) has filed a Form 3 on Novus Therapeutics, Inc. |
|
|